Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients

NCT03562130 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: Teduglutide

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]